Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29,437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
Chen B, Zhu SY, Shi M, Su H, Wang Y, He X, Xu LM, Yuan ZY, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Wu T, Qi SN, Yang Y, Liu X, Li YX. Chen B, et al. Cancer Med. 2018 Dec;7(12):5952-5961. doi: 10.1002/cam4.1849. Epub 2018 Oct 24. Cancer Med. 2018. PMID: 30358175 Free PMC article.
First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in China.
Chai Y, Chen B, Qi F, Fang H, Qi SN, Guo RY, Li N, Yang Y, Wang SL, Song YW, Yang JL, Zhang D, Wei YC, Li YX, Dong M. Chai Y, et al. Among authors: chen b. Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):833-844. doi: 10.1016/j.ijrobp.2022.04.001. Epub 2022 Apr 20. Int J Radiat Oncol Biol Phys. 2022. PMID: 35452752 Clinical Trial.
Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study.
Qi F, Wang WH, He XH, Chen B, Gui L, Fang H, Liu P, Wang SL, Yang JL, Song YW, Yang S, Qi SN, Zhou SY, Li YX, Dong M. Qi F, et al. Among authors: chen b. Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):61-70. doi: 10.1016/j.ijrobp.2018.05.046. Epub 2018 May 29. Int J Radiat Oncol Biol Phys. 2018. PMID: 30102205 Clinical Trial.
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.
Wu T, Yang Y, Zhu SY, Shi M, Su H, Wang Y, He X, Xu LM, Yuan ZY, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Hu C, Qi SN, Chen B, Li YX. Wu T, et al. Among authors: chen b. Blood Adv. 2018 Sep 25;2(18):2369-2377. doi: 10.1182/bloodadvances.2018021311. Blood Adv. 2018. PMID: 30242098 Free PMC article.
Radiotherapy plays an important role in improving the survival outcome in patients with T1-2N1M0 breast cancer - a joint analysis of 4262 real world cases from two institutions.
Sun GY, Wen G, Zhang YJ, Tang Y, Jing H, Wang JY, Zhang JH, Yang Y, Zhao XR, Chen SY, Jin J, Song YW, Liu YP, Fang H, Ren H, Tang Y, Qi SN, Li N, Chen B, Lu NN, Wang SL, Li YX. Sun GY, et al. Among authors: chen b, chen sy. BMC Cancer. 2020 Nov 26;20(1):1155. doi: 10.1186/s12885-020-07646-y. BMC Cancer. 2020. PMID: 33243177 Free PMC article.
Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015).
Wu Y, Liu X, Imber BS, Zhong QZ, Yang Y, Wu T, Chen SY, Chen B, Song YW, Fang H, Jin J, Liu YP, Jing H, Tang Y, Li N, Lu NN, Wang SL, Chen F, Yin L, Zhang XM, Zhu J, Tsang RW, Yahalom J, Hu C, Men K, Deng M, Xia C, Li YX, Qi SN. Wu Y, et al. Among authors: chen b, chen sy, chen f. Radiother Oncol. 2022 Aug;173:179-187. doi: 10.1016/j.radonc.2022.05.034. Epub 2022 Jun 3. Radiother Oncol. 2022. PMID: 35667572
Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial.
Chen SY, Sun GY, Tang Y, Jing H, Song YW, Jin J, Liu YP, Zhao XR, Song YC, Chen B, Qi SN, Tang Y, Lu NN, Li N, Fang H, Li YX, Wang SL. Chen SY, et al. Among authors: chen b. Eur J Cancer. 2022 Oct;174:153-164. doi: 10.1016/j.ejca.2022.07.023. Epub 2022 Aug 20. Eur J Cancer. 2022. PMID: 35998550 Free article. Clinical Trial.
29,437 results
You have reached the last available page of results. Please see the User Guide for more information.